![Kristin Stafford](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristin Stafford
Finanzdirektor/CFO bei
ZYMEWORKS INC.
Vermögen: 365 797 $ am 30.09.2026
Profil
Ms. Kristin Stafford, CPA, is a Chief Financial Officer & Executive Vice President at Zymeworks, Inc., an Independent Director at NovoCure Ltd. and a Chief Accounting Officer & Senior Vice President at Royalty Pharma Plc.
She is on the Board of Directors at Theravance Biopharma, Inc. and NovoCure Ltd. Ms. Stafford was previously employed as a Chief Financial Officer by BioPharma Credit PLC, a Director-Capital Markets by Ernst & Young LLP (United Kingdom), and an Auditor by Deloitte & Touche LLP.
She received her undergraduate degree from Sonoma State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NOVOCURE LTD. 0.02% | 03.06.2026 | 22’934 ( 0.02% ) | 365 797 $ | 30.09.2026 |
Aktive Positionen von Kristin Stafford
| Unternehmen | Position | Beginn |
|---|---|---|
| ROYALTY PHARMA PLC | Comptroller/Controller/Auditor | 01.12.2018 |
| NOVOCURE LIMITED | Direktor/Vorstandsmitglied | 28.03.2023 |
| ZYMEWORKS INC. | Finanzdirektor/CFO | 01.04.2026 |
| THERAVANCE BIOPHARMA | Direktor/Vorstandsmitglied | 23.09.2026 |
Ehemalige bekannte Positionen von Kristin Stafford
| Unternehmen | Position | Ende |
|---|---|---|
| BIOPHARMA CREDIT PLC | Finanzdirektor/CFO | 01.01.2018 |
Ernst & Young LLP (United Kingdom)
 Ernst & Young LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Provides assurance, tax consulting, strategy, transactions and risk advisory services | Corporate Officer/Principal | 01.12.2016 |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Comptroller/Controller/Auditor | 01.05.2008 |
Ausbildung von Kristin Stafford
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Sonoma State University
 Sonoma State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young LLP (United Kingdom)
Ernst & Young LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Provides assurance, tax consulting, strategy, transactions and risk advisory services | Commercial Services |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
BioPharma Credit PLC
 BioPharma Credit PLC Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
